Praduman Jain (PJ), is the Principal Investigator of a research project funded by NIH RADx TECH program to build next-generation technology for infectious disease screening, early detection and testing. Jain is also a Principal Investigator of the Technology Center of the NIH All of Us Research Program, Principal Investigator of the NIH AIM AHEAD and Founder & CEO of Vibrent Health. Under Jain’s leadership, the NIH awarded Vibrent $75 million in 2016 and an additional award in 2020, with initial funding of $39 million, to build and manage a national digital platform for health research for one million people across the U.S. over the program’s expected span of 10 or more years.

Jain is an invited member of the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Genomics and Precision Health and a board member of the George Mason University School of Public Health. Prior to founding Vibrent, Jain held various senior leadership roles at Sprint, Nextel, AOL, Time Warner, and VTech and launched several emerging products and services. He earned MS and BS degrees in electrical engineering, holds several patents and has authored several peer-reviewed publications.